$1.26
3M Ago | 1M Ago | Current | |
Buy | 1 | 1 | 1 |
Outperform | 0 | 0 | 0 |
Hold | 9 | 9 | 9 |
Underperform | 2 | 2 | 2 |
Sell | 2 | 2 | 2 |
The latest share price target for Cytomx Therapeutics Inc (CTMX) is $2.49, offered by 14 analysts offering 12-month price forecasts.
Cytomx Therapeutics Inc (CTMX) has a maximum of 0.98 upside potential, based on 14 analysts offering 12-month price forecasts.
Based on 14 analysts tracking and researching Cytomx Therapeutics Inc (CTMX), 64.29% have a hold recommendation. Remaining 35.71% have either buy or sell recommendations.
The latest share price of Cytomx Therapeutics Inc (CTMX) is $1.26 as of 27/09/2023.
9 of total 14 analysts offering stock ratings for Cytomx Therapeutics Inc CTMX have recommended hold rating.